Arla Foods Ingredients targets GLP‑1 nutrition

Arla Foods Ingredients has developed a new range of high‑protein, functional application concepts built around its Nutrilac and Lacprodan BLG‑100 whey protein solutions.

The concepts include fermented shots, drinking yogurts, spoonable yogurts and an ambient water‑based protein shot, all designed to deliver essential amino acids in nutrient‑dense formats suitable for smaller serving sizes.

GLP‑1 receptor agonists — originally developed for diabetes — have reshaped the weight‑management market. In 2025, 11% of global consumers and 18% of US consumers actively trying to lose weight reported using them, with uptake expected to rise as availability expands and tablet formats emerge. However, GLP‑1 use is associated with significant nutritional challenges: lean muscle loss can reach 40% of total mass lost, and up to 76% of users report gastric discomfort and reduced appetite. These factors are driving demand for nutrient‑dense, high‑protein foods that are easy to digest and suitable for smaller portions.

The new concepts feature Nutrilac and Lacprodan BLG‑100, delivering complete essential amino acid profiles to support muscle health. They also incorporate probiotics and cultures from Novonesis to support digestive well‑being — a key concern for GLP‑1 users experiencing nausea, stomach pain or reduced appetite. Formats include:

• A fermented high‑protein shot with 10g protein per 70ml
• A fermented drinking yogurt with 20g protein per 200ml
• A spoonable yogurt with 20g protein per 120g
• A water‑based ambient protein shot with 21g protein per 100ml

All are low in fat, lactose‑reduced or lactose‑free, and designed to be palatable for consumers with reduced appetite.

The concepts are aimed at dairy manufacturers, nutrition brands, and functional food producers seeking to develop products tailored to GLP‑1 users — a rapidly expanding consumer segment with specific protein, digestion and portion‑size needs.

Arla Foods Ingredients will showcase the full GLP‑1 companion nutrition range at Vitafoods Europe (5–7 May 2026, Barcelona), positioning the concepts as turnkey formulation solutions that manufacturers can adapt into commercial products. The company is also presenting complementary innovations, including an aerated protein bar concept and ready‑to‑stir medical nutrition powders, broadening its offer across high‑protein categories.

Arla Foods Ingredients aims to lead the emerging GLP‑1 companion nutrition category by providing science‑backed, application‑ready solutions. Chief commercial officer Anne Widart said the category represents “a growing opportunity for dairy manufacturers,” with rising demand for nutrient‑dense, high‑protein products that support muscle maintenance and digestive comfort.

The rise of GLP‑1 medications is creating a new functional‑nutrition segment that prioritises muscle preservation, digestive support and high nutrient density in smaller portions. Arla Foods Ingredients’ concepts give manufacturers a ready‑made toolkit to enter this space quickly, backed by clinically relevant protein solutions and consumer‑friendly formats.